At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,204 enrolled
Drug / intervention
PAD endovascular treatmentsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LIBERTY 360: Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients With Distal Outflow Peripheral Arterial Disease (PAD)
In Brief
An observational study evaluating PAD endovascular treatments for Peripheral Arterial Occlusive Disease. Completed, enrolled 1,204 participants across 52 sites.
Detailed Summary
The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Occlusive Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedMay 2013
Primary CompletionApr 2019
TodayJul 2026
First PostedMay 16, 2013
Enrollment StartMay 1, 2013
Primary CompletionApr 11, 2019
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 13.1 years ago
Interventions
PAD endovascular treatmentsother
All FDA-cleared endovascular PAD treatments